![David-Alexandre Gros](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David-Alexandre Gros
Directeur Général chez
ELEDON PHARMACEUTICALS, INC.
Fortune : 13 M $ au 31/05/2026
Profil
Dr. David-Alexandre C.
Gros is a Chief Executive Officer & Director at Eledon Pharmaceuticals, Inc. He is on the Board of Directors at Eledon Pharmaceuticals, Inc. Dr. Gros was previously employed as a Chairman & Chief Executive Officer by Sabeton SA, a Chairman & Chief Executive Officer by Imbria Pharmaceuticals, Inc., a President, Chief Operating & Financial Officer by Neurocrine Biosciences, Inc., a Chief Financial Officer by Alnylam Pharmaceuticals, Inc., a Member-Supervisory Board by Sabeton SA, a Chief Strategy Officer & Executive Vice President by Sanofi, a Chief Strategy Officer by Sanofi, a Principal by Centerview Partners LLC, and an Associate Principal by McKinsey & Co., Inc. He also served on the board at Eliem Therapeutics, Inc. He received his undergraduate degree from Dartmouth College, an MBA from Harvard Business School and a doctorate degree from The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAINT JEAN GROUPE SA 15,62% | 07/05/2026 | 500 000 ( 15,62% ) | 13 M $ | 31/05/2026 |
| 31/03/2026 | 9 000 ( 0,01% ) | 34 290 $ | 31/05/2026 |
Postes actifs de David-Alexandre Gros
| Sociétés | Poste | Début |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Directeur Général | 09/09/2020 |
Anciens postes connus de David-Alexandre Gros
| Sociétés | Poste | Fin |
|---|---|---|
| SAINT JEAN GROUPE | Directeur Général | 30/06/2026 |
| CLIMB BIO, INC. | Fondateur | 01/10/2020 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Directeur Général | 01/09/2020 |
| NEUROCRINE BIOSCIENCES, INC. | President | 31/12/2017 |
| ALNYLAM PHARMACEUTICALS, INC. | Directeur Financier/CFO | 06/01/2017 |
Formation de David-Alexandre Gros
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saint Jean Groupe SA
 Saint Jean Groupe SA Food: Major DiversifiedConsumer Non-Durables Operates as an investment holding company with the interest in agro foods sector | Consumer Non-Durables |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Centerview Partners LLC
 Centerview Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Choisissez Zonebourse 
